Search research articles
Contact Us
Filters
Showing results (81-90 of 163) with videos related to
Page
of 17
Sort By:
Parasites & Vectors
|
July 9, 2016
Immunomodulatory effects of tick saliva on dermal cells exposed to Borrelia burgdorferi, the agent of Lyme disease
Dorothy C Scholl, Monica E Embers, John R Caskey, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Single dose alum adjuvanted RBD protein vaccine provides protection against homologous challenge with SARS-CoV-2 Washington strain and heterologous rechallenge with Delta and Omicron BA.5 variants in K18 hACE2 mouse model
Rajesh Thippeshappa, Viraj Kulkarni, Varun Dwivedi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 13, 2022
Animal Models of COVID-19: Nonhuman Primates
Dhiraj K Singh, Journey Cole, Ruby A Escobedo, et al.
Research Square
|
September 11, 2024
Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation
Riti Sharan, Yi Zou, Zhao Lai, et al.
Plos One
|
January 12, 2012
The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes
Noton K Dutta, Smriti Mehra, Alejandra N Martinez, et al.
The Journal of Infectious Diseases
|
December 14, 2019
Mycobacterium tuberculosis HN878 Infection Induces Human-Like B-Cell Follicles in Mice
José Alberto Choreño-Parra, Suhas Bobba, Javier Rangel-Moreno, et al.
Infection and Immunity
|
March 7, 2024
Phospholipase C epsilon-1 (PLCƐ1) mediates macrophage activation and protection against tuberculosis
Ananya Gupta, Shyamala Thirunavukkarasu, Javier Rangel-Moreno, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 13, 2002
Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH
Deepak Kaushal, Benjamin G Schroeder, Sandeep Tyagi, et al.
Cell Reports
|
June 22, 2022
Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes
Sadia Akter, Kuldeep S Chauhan, Micah D Dunlap, et al.
Infection and Immunity
|
December 6, 2017
Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design
Dominick J Laddy, Aurelio Bonavia, Willem A Hanekom, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 163) with videos related to
Sort By:
Page
of 17
Parasites & Vectors
|
July 9, 2016
Immunomodulatory effects of tick saliva on dermal cells exposed to Borrelia burgdorferi, the agent of Lyme disease
Dorothy C Scholl, Monica E Embers, John R Caskey, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Single dose alum adjuvanted RBD protein vaccine provides protection against homologous challenge with SARS-CoV-2 Washington strain and heterologous rechallenge with Delta and Omicron BA.5 variants in K18 hACE2 mouse model
Rajesh Thippeshappa, Viraj Kulkarni, Varun Dwivedi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 13, 2022
Animal Models of COVID-19: Nonhuman Primates
Dhiraj K Singh, Journey Cole, Ruby A Escobedo, et al.
Research Square
|
September 11, 2024
Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation
Riti Sharan, Yi Zou, Zhao Lai, et al.
Plos One
|
January 12, 2012
The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes
Noton K Dutta, Smriti Mehra, Alejandra N Martinez, et al.
The Journal of Infectious Diseases
|
December 14, 2019
Mycobacterium tuberculosis HN878 Infection Induces Human-Like B-Cell Follicles in Mice
José Alberto Choreño-Parra, Suhas Bobba, Javier Rangel-Moreno, et al.
Infection and Immunity
|
March 7, 2024
Phospholipase C epsilon-1 (PLCƐ1) mediates macrophage activation and protection against tuberculosis
Ananya Gupta, Shyamala Thirunavukkarasu, Javier Rangel-Moreno, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 13, 2002
Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH
Deepak Kaushal, Benjamin G Schroeder, Sandeep Tyagi, et al.
Cell Reports
|
June 22, 2022
Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes
Sadia Akter, Kuldeep S Chauhan, Micah D Dunlap, et al.
Infection and Immunity
|
December 6, 2017
Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design
Dominick J Laddy, Aurelio Bonavia, Willem A Hanekom, et al.
Page
of 17